Carisma Therapeutics

1 follower


Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy to treat solid tumors.

Org chart

Steven Kelly
President & CEO

Steven Kelly

Collapse
Michael Klichinsky
Co-Founder & SVP, Discovery Research
Richard Morris
Chief Financial Officer
Tom Wilton
Chief Business Officer
Eric Siegel
General Counsel & Corporate Secretary
Terry Shields
SVP, Human Resources
Kenneth Locke
VP, Manufacturing & Supply Chain
Maggie Wesberry Schmierer
Director, Analytical Sciences And Quality Control
Andrew Best
Manager, Process Development
Isaac Zentner
Director, Cmc/manufacturing Operations
Nicholas Minutolo
Associate Director, Research